CompletedNot applicableNCT00004443
Study of NTBC for Tyrosinemia I
Studying Tyrosinemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Washington
- Principal Investigator
- C. Ronald ScottUniversity of Washington
- Intervention
- NTBC(drug)
- Enrollment
- 20 enrolled
- Eligibility
- 17 years · All sexes
- Timeline
- 1998 – 2006
Study locations (3)
- Oregon Health Sciences University, Portland, Oregon, United States
- University of Washington School of Medicine, Seattle, Washington, United States
- Hopital Sainte Justine, Montreal, Quebec, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00004443 on ClinicalTrials.gov